A Deadline is coming up on September 25, 2018in the lawsuit for investors in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) and NASDAQ:TTPH stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 09/26/2018 -- The Shareholders Foundation announces that a deadline is coming up on September 25, 2018 in the lawsuit filed for certain investors in NASDAQ:TTPH shares over alleged securities laws violations by Tetraphase Pharmaceuticals Inc.
Investors who purchased shares of Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) have certain options and there are strict and short deadlines running. Deadline: September 25, 2018. NASDAQ:TTPH stockholders should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) securities pursuant and/or traceable to the Company's allegedly false and/or misleading registration statement and prospectus issued in connection with the Company's July 2017 secondary public offering ("SPO" or the "Offering"); and/or acquired Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) securities between March 8, 2017 and February 13, 2018, that the defendants violated Federal Securities Laws.
More specifically, the plaintiff claims that between March 8, 2017 and February 13, 2018, the defendants failed to disclose, that Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) was increasing the patient enrollment in its IGNITE3 trial from 1,000 patients to 1,200 patients to meet the trial's primary endpoints (within the 10% non-inferiority margin), that the enrollment of more patients in the trial indicated that the existing population was inadequate to meet the trial's primary endpoints, and that, as a result of the foregoing, Defendants' statements about Tetraphase's business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.
Those who purchased shares of Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels